Zhang TY, Ge AY, Hutchinson L, Higgins AW, et al. Limited Survival Benefit and High Healthcare Utilization With AML-Directed Therapy in Older Patients With TP53-Mutated Acute Myeloid Leukemia. Am J Hematol 2026 Jun 22. doi: 10.1002/ajh.70422.
PMID: 42332361